| 1 | [SID49670109] | Active | Potency | 0.8913 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 2 | [SID49670109] | Active | Potency | 0.8913 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 3 | [SID49670109] | Active | Potency | 11.2202 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 4 | [SID49670109] | Active | Potency | 11.2202 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 5 | [SID49670109] | Active | Potency | 12.5893 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 6 | [SID49670109] | Active | Potency | 39.8107 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 7 | [SID49670109] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID49670109] | Active | | | Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | BioAssay | Aqueous Solubility from MLSMR Stock Solutions | | AID | 1996 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID49670109] | Active | | | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity [AID504408, Type: screening] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | BioAssay | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity | | AID | 504408 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID49670109] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 11 | [SID49670109] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 12 | [SID49670109] | Active | | | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). [AID1822, Type: screening] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | BioAssay | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). | | AID | 1822 | | BioAssay type | screening | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 13 | [SID49670109] | Active | | | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). [AID1822, Type: screening] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | BioAssay | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). | | AID | 1822 | | BioAssay type | screening | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 14 | [SID49670109] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 15 | [SID49670109] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 16 | [SID49670109] | Active | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|
| 17 | [SID49670109] | Active | | | Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA) [AID602163, Type: screening] | MSRA protein [Bos taurus] [gi:73586699] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Active | | BioAssay | Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA) | | AID | 602163 | | BioAssay type | screening | | Target | MSRA protein [Bos taurus] [gi:73586699] | | PubMed | | | Data Table |  |
|
| 18 | [SID49670109] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 19 | [SID49670109] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 20 | [SID49670109] | Inactive | Potency | 11.2202 | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression [AID624202, Type: confirmatory] | BRCA1 [Homo sapiens] [gi:1698399] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression | | AID | 624202 | | BioAssay type | confirmatory | | Target | BRCA1 [Homo sapiens] [gi:1698399] | | PubMed | | | Data Table |  |
|
| 21 | [SID49670109] | Inactive | Potency | 11.2202 | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression [AID624202, Type: confirmatory] | BRCA1 [Homo sapiens] [gi:1698399] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression | | AID | 624202 | | BioAssay type | confirmatory | | Target | BRCA1 [Homo sapiens] [gi:1698399] | | PubMed | | | Data Table |  |
|
| 22 | [SID49670109] | Inactive | Potency | 11.2202 | qHTS Assay for Inhibitors of Influenza NS1 Protein Function [AID2326, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Influenza NS1 Protein Function | | AID | 2326 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] | | PubMed | | | Data Table |  |
|
| 23 | [SID49670109] | Inactive | Potency | 35.4813 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID49670109] | Inactive | Potency | 100 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | 100 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 25 | [SID49670109] | Inactive | Potency | 100 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | 100 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 26 | [SID49670109] | Inactive | Potency | | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 27 | [SID49670109] | Inactive | Potency | | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 28 | [SID49670109] | Inactive | Potency | | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 29 | [SID49670109] | Inactive | Potency | | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 30 | [SID49670109] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 31 | [SID49670109] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 32 | [SID49670109] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 33 | [SID49670109] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 34 | [SID49670109] | Inactive | | | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493012, Type: screening] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493012 | | BioAssay type | screening | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 35 | [SID49670109] | Inactive | Potency | | qHTS for Inhibitors of Vif-A3G Interactions: qHTS [AID602310, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3G Interactions: qHTS | | AID | 602310 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 36 | [SID49670109] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 37 | [SID49670109] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 38 | [SID49670109] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 39 | [SID49670109] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 40 | [SID49670109] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 41 | [SID49670109] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 42 | [SID49670109] | Inactive | | | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase [AID2805, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase | | AID | 2805 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 43 | [SID49670109] | Inactive | | | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase [AID2806, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase | | AID | 2806 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 44 | [SID49670109] | Inactive | Potency | | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504466, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504466 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 45 | [SID49670109] | Inactive | Potency | | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 46 | [SID49670109] | Inactive | | | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) [AID493160, Type: screening] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) | | AID | 493160 | | BioAssay type | screening | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 47 | [SID49670109] | Inactive | | | uHTS Fluorescent assay for identification of activators of hexokinase domain containing I (HKDC1) [AID493187, Type: screening] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent assay for identification of activators of hexokinase domain containing I (HKDC1) | | AID | 493187 | | BioAssay type | screening | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 48 | [SID49670109] | Inactive | IC50 | | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2073, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay | | AID | 2073 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 49 | [SID49670109] | Inactive | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 50 | [SID49670109] | Inactive | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49670109 | | CID | 56642855 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|